General MedicationsORALGeneric
POVAN
PYRVINIUM PAMOATE
Standard Dose
EQ 50MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview POVAN is listed in Drugs@FDA under application 012485 (NDA).
Marketing status: Discontinued Active ingredient PYRVINIUM PAMOATE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview POVAN is listed in Drugs@FDA under application 012485 (NDA). Marketing status: Discontinued Active ingredient PYRVINIUM PAMOATE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.